A flexible partnership model helps Bayer and BlueRock fast-track groundbreaking cell therapies for diseases like Parkinson’s.

Inside ASCO 2025: Big data drops and a towering campaign

Biopharma and medtech explained. Every week, journalists from Fierce Biotech, Fierce Medtech, and Fierce Pharma recount the latest industry trends and why they matter. We'll analyze the week's biggest business news, from mergers and marketing to drug R&amp;D and device development. Available every Friday morning.&nbsp;